FDA Pushes To Authorize Novavax’s Covid-19 Vaccine Despite Serious Cardiovascular Safety Issues

Despite overwhelming evidence of the harm the Covid vaccines do and the FDA’s admission that the vaccine carried the possible risk of causing heart inflammation, particularly in young males, similar to the Pfizer, Moderna, and AstraZeneca mRNA vaccines, they are pushing to authorize this poison.

The lies and deceit are monumentally criminal …… And the Medical establishment has destroyed the public trust by going along with this horror.

Sudden death is the most catastrophic contraindication of the vaccine but its effects are systemic, The uterus is also a biologically active organ because it’s always preparing a new inner wall monthly then tearing it down and starting again in a menstruating woman so that’s another big target of shitty spike vaccine.

And remember Covid19 vaccine has been linked to prion disease which is an incurable brain disease, a dementia like Creutzfeldt-Jakob.

We warned you all! Corona bioweapon vaccines don’t work and they are dangerous and deadly. @pfizer #Pfizer 🤬🤬🤬🤬🤬🤬🤬🤬🤬🤬🤬🤬🤬 https://t.co/j721tbeiFQ

— calfit32 🇺🇸 #Unvaccinated (@calfit32) June 5, 2022

You are some sick, sick, sick and deeply disturbed people @ashishkjha

— Kyle Becker (@kylenabecker) June 2, 2022

FDA Pushes To Authorize Novavax’s Covid-19 Vaccine Despite Serious Cardiovascular Safety Issues

The FDA appears to have lost its high standard for drug safety and efficacy, and it is the American public who will suffer.

By: David Gortler, The Federalist, June 9, 2022:

Earlier this week, the U.S. Food and Drug Administration (FDA) had a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss an emergency-use authorization (EUA) request by Novavax for its vaccine to prevent Covid-19 in individuals 18 years of age and older. The committee voted to approve it.

It is clear that there is a noteworthy adverse event signal, especially cardiovascular-related events, following existing Covid vaccines and boosters. Based on available evidence, there is no reason to think the Novavax vaccine will be any different. Indeed, the FDA review of the Novavax “protein subunit” vaccine acknowledged the vaccine carried the possible risk of causing heart inflammation, particularly in young males, similar to the Pfizer, Moderna, and AstraZeneca mRNA vaccines.

In addition to the medical review, the FDA’s Vaccine Adverse Event Reporting System (VAERS) database for Covid-19 vaccines shows a significant number of cardiovascular-related events in young healthy people in particular. To date, there are tens of thousands of reports of heart attack, myocarditis, or pericarditis in the United States alone.

The United States alone has accumulated a list of more than 800,000 reports of adverse events associated with these vaccines, with even more adverse events reported worldwide. Moreover, reported cases are well known to represent only 1–10 percent of the adverse events that occur in actuality. In short, the sheer number of cases — something we’ve never seen before — is cause for alarm to drug safety experts like myself.

Myocarditis and pericarditis used to be considered rare conditions. They are defined as inflammation of the heart muscle or layers of the pericardial sac, respectively. Both conditions cause easily recognizable echocardiogram (ECG) changes and have nonspecific symptoms that include shortness of breath and chest pain.

They can easily be diagnosed clinically with ECGs and treated by pharmacology, but in order for physicians to do that, the FDA label must recommend physicians look for certain symptoms immediately following Covid-19 vaccination. Failing to immediately diagnose myocarditis or pericarditis could have fatal consequences.

These cardiovascular adverse events were warned about in the FDA medical review of the Pfizer application, and the FDA receives new reports on cardiovascular adverse events on a daily basis. The FDA’s medical officer review, which was the basis for approving the Pfizer vaccine, notes that “clinically important serious adverse reactions [were] anaphylaxis and myocarditis/pericarditis.”

Patients Not Warned of Risks

But the problem is patients were — and are still — not being adequately warned or monitored for cardiovascular symptoms on existing Covid-19 vaccines. Pfizer should already have placed a warning on the label.

Pfizer, Moderna, and AstraZeneca should have already volunteered to warn all their patients about potentially deadly cardiovascular adverse events, as well as other adverse events trending upward in VAERS that are associated with Covid vaccine and booster administration. At a minimum, any Novavax vaccine should have a prominent warning informing the public about the risk of potential serious and deadly cardiovascular adverse events, but since Pfizer and Moderna aren’t doing so, neither is Novavax.

Adverse events from drugs were already the fourth leading cause of death prior to the Covid-19 pandemic, according to the FDA. Because Pfizer and Moderna’s cardiovascular and other adverse events were not taken seriously enough by the FDA to warrant more substantial labeling warnings, Covid-19 vaccine adverse events have become a major source of morbidity and mortality, per the FDA’s VAERS reporting system.